NEMP1

Across TCGA pan-cancer cohorts, NEMP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated NEMP1 data layer compared with 29 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NEMP1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NEMP1 expression acts as an unfavorable survival marker.

UCEC, CCRCC, and LUAD are the cancer types where NEMP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.936	1.000	.022	28	view →
CCRCC	DFS	Median	III,IV	0.392	0.897	.012	10	view →
LUAD	DFS	Median	II,III,IV	0.324	0.714	.028	5	view →
LSCC	OS	Quartile	All	0.785	1.000	.047	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NEMP1–UCEC (DFS)

Open the UCEC breakdown →